NCT07885150

Brief Summary

Background: AI (artificial intelligence) tools are increasingly used to help clinicians interpret medical images such as X-rays, scans, skin photographs and eye images. In most cases the AI does not work alone: a clinician makes the final decision, using the AI as support. Before these tools are used in the NHS, they must be tested to show they are safe and helpful. They are usually tested in a "reader study", where several clinicians each interpret the same set of images, sometimes with the AI's help and sometimes without, so performance can be compared. These studies tend to focus on whether the diagnosis was correct. However, accuracy alone may not measure everything that matters. For example, what happens when the AI gets it wrong, whether clinicians rely on it too much or too little, or how the tool affects efficiency. At present there is no agreed standard for what these studies should measure, so important things are often missed and studies are hard to compare. Aim: The aim of this study is to find out, by talking to people with different perspectives, which outcomes are important when evaluating AI tools that help clinicians read medical images. Objectives:

  1. 1.Explore which outcomes people think matter when judging whether an AI tools is safe and good enough to use
  2. 2.Understand the reasons behind their views
  3. 3.Explore how priorities differ between groups, such as patients and developers.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
12mo left

Started Oct 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Oct 2026Oct 2027

First Submitted

Initial submission to the registry

October 8, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

October 16, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2027

Last Updated

October 21, 2026

Status Verified

October 1, 2026

Enrollment Period

9 months

First QC Date

October 8, 2026

Last Update Submit

October 15, 2026

Conditions

Keywords

artificial intelligenceperspectivescore outcome set

Outcome Measures

Primary Outcomes (1)

  • Qualitative themes and subthemes

    Day 1 (interview date) through study completion (1 year)

Secondary Outcomes (1)

  • Number of participants per stakeholder group

    Day 1

Other Outcomes (3)

  • Participant age

    Day 1

  • Participant sex

    Day 1

  • Participant professional background

    Day 1

Study Arms (6)

Patients and the public

Clinicians

Representatives of UK regulatory bodies

Researchers and methodologists

Hospital managers and procurers

Developers of AI image-interpretation tools

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The investigators expect to involve approximately 24-30 participants in total, each taking part in a single interview. Participants will be purposively sampled across the following stakeholder groups, with roughly equal numbers. A key priority is to achieve a rich spread of perspectives within and across the groups.

You may qualify if:

  • Membership of one of the following stakeholder groups:
  • Clinicians who interpret medical images (e.g. radiologists, dermatologists, ophthalmologists, pathologists, and trainees in these specialties)
  • Researchers and methodologists who design or analyse studies of these tools
  • Developers of AI image-interpretation tools
  • Regulatory, health-technology-assessment and policy stakeholders
  • Patients and members of the public, including people affected by conditions diagnosed using medical imaging
  • Hospital managers and procurers

You may not qualify if:

  • Involvement in study design
  • Unable to speak fluent English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences

Oxford, OX37LD, United Kingdom

Location

MeSH Terms

Conditions

Behavior

Study Officials

  • Dominic Furniss, DM MA MBBCh FRCS

    University of Oxford

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2026

First Posted

October 21, 2026

Study Start

October 16, 2026

Primary Completion (Estimated)

July 16, 2027

Study Completion (Estimated)

October 16, 2027

Last Updated

October 21, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Qualitative interview data may include sensitive personal health, commercial, or regulatory information.

Locations